Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Tavec Inc.
DescriptionExosome-mediated miRNA injectable
Molecular Target
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: microRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationBiliary cancer
Indication DetailsTreat cholangiocarcinoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today